Clinical Trial Update: Effects of Oral Levosimendan on Ambulatory Electrocardiographic Variables [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effects of oral levosimendan on ambulatory electrocardiographic variables in patients with transient ischemic attack or stroke; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Drugs mentioned

• Levosimendan (levosimendan)

Snippet

Sponsor: Orion Corporation, Orion Pharma | Conditions: Transient Ischemic Attack, Stroke | Phase 2 | Status: COMPLETED